The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

  • Feng‐Hua Wang
    Department of Medical Oncology Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China
  • Lin Shen
    Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
  • Jin Li
    Department of Oncology, Shanghai East Hospital Tongji University School of Medicine Shanghai 200120 P. R. China
  • Zhi‐Wei Zhou
    Department of Gastric Surgery Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China
  • Han Liang
    Department of Gastric Cancer Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center of Cancer, Tianjin's Clinical Research Cancer for Cancer, Key Laboratory of Cancer Prevention and Therapy Tianjin 300060 P. R. China
  • Xiao‐Tian Zhang
    Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
  • Lei Tang
    Medical Imaging Department, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
  • Yan Xin
    Pathology Laboratory of Gastrointestinal Tumor The First Hospital of China Medical University Shenyang 110001 Liaoning P. R. China
  • Jing Jin
    Department of Radiation Oncology, National Cancer Center China and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China
  • Yu‐Jing Zhang
    Department of Radiotherapy Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China
  • Xiang‐Lin Yuan
    Department of Medical Oncology Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan 430030 Hubei P. R. China
  • Tian‐Shu Liu
    Department of Medical Oncology Zhongshan Hospital Affiliated to Fudan University Shanghai 200032 P. R. China
  • Guo‐Xin Li
    Department of General Surgery Nanfang Hospital Affiliated to Southern Medical University Guangzhou 510515 Guangdong P. R. China
  • Qi Wu
    Department of Endoscopy Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
  • Hui‐Mian Xu
    Department of Surgical Oncology The First Hospital of China Medical University Shenyang 110001 Liaoning P. R. China
  • Jia‐Fu Ji
    Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology Peking University Cancer Hospital and Institute Beijing 100142 P. R. China
  • Yuan‐Fang Li
    Department of Gastric Surgery Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China
  • Xin Wang
    Department of Radiation Oncology, National Cancer Center China and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 P. R. China
  • Shan Yu
    Department of Medical Oncology Zhongshan Hospital Affiliated to Fudan University Shanghai 200032 P. R. China
  • Hao Liu
    Department of General Surgery Nanfang Hospital Affiliated to Southern Medical University Guangzhou 510515 Guangdong P. R. China
  • Wen‐Long Guan
    Department of Medical Oncology Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China
  • Rui‐Hua Xu
    Department of Medical Oncology Sun Yat‐sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine Guangzhou 510060 Guangdong P. R. China

Description

<jats:title>Abstract</jats:title><jats:p>China is one of the countries with the highest incidence of gastric cancer. There are differences in epidemiological characteristics, clinicopathological features, tumor biological characteristics, treatment patterns, and drug selection between gastric cancer patients from the Eastern and Western countries. Non‐Chinese guidelines cannot specifically reflect the diagnosis and treatment characteristics for the Chinese gastric cancer patients. The Chinese Society of Clinical Oncology (CSCO) arranged for a panel of senior experts specializing in all sub‐specialties of gastric cancer to compile, discuss, and revise the guidelines on the diagnosis and treatment of gastric cancer based on the findings of evidence‐based medicine in China and abroad. By referring to the opinions of industry experts, taking into account of regional differences, giving full consideration to the accessibility of diagnosis and treatment resources, these experts have conducted experts’ consensus judgement on relevant evidence and made various grades of recommendations for the clinical diagnosis and treatment of gastric cancer to reflect the value of cancer treatment and meeting health economic indexes. This guideline uses tables and is complemented by explanatory and descriptive notes covering the diagnosis, comprehensive treatment, and follow‐up visits for gastric cancer.</jats:p>

Journal

Citations (2)*help

See more

Report a problem

Back to top